Autologous mucosa graft prevent Post-ESD esophageal stenosis in early esophageal cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049846

Enrollment

Unknown

Registered

2021-08-10

Start date

2021-08-06

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early esophageal cancer

Interventions

autologous mucosa graft group:None

control group:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Preoperative pathology confirmed early esophageal cancer or high-grade intraepithelial neoplasia; 2. Preoperative examination to exclude regional lymph nodes and distant metastasis; 3. The extent of the lesion involves more than 3/4 weeks of the esophagus; 4. Preoperative assessment can tolerate ESD surgery.

Exclusion criteria

Exclusion criteria: 1. Postoperative pathological confirmation of lesions beyond the indications of ESD curative resection, requiring additional surgery or radiochemotherapy; 2. Perforation occurs during ESD or during expansion, and is not suitable for hormone therapy; 3. Patients and their families cannot sign the informed consent.

Design outcomes

Primary

Measure	Time frame
Degree of esophageal stenosis;	—

Countries

China

Contacts

Public ContactQi Conghu

Zoucheng People’s Hospital

66229183@qq.com+86 15153789151

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026